CUFinder

Hongyun Zhao

Hongyun Zhao

Harvard University

H-index: 9

North America-United States

Contact Hongyun Zhao

About Hongyun Zhao

Hongyun Zhao, With an exceptional h-index of 9 and a recent h-index of 8 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cell/gene therapy, Immunometabolism, Cancer metabolism, Tumor microenvironment, Extracellular.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract LB027: In vivo delivery of novel CD89 fusion receptor to myeloid cells by mRNA activates anti-tumor immunity

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth

Abstract LB006: In vivo programming of myeloid cells by mRNA mediated delivery of novel Fc alpha fusion receptor activates anti-tumor immunity

1237 In vivo programming of myeloid cells by mRNA mediated delivery of novel Fca fusion receptor activates anti-tumor immunity

Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment

ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment

Hongyun Zhao Information

University

Position

Postdoc Research Fellow, Massachusetts General Hospital, Harvard Medical School

Citations(all)

1572

Citations(since 2020)

1215

Cited By

842

hIndex(all)

9

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Hongyun Zhao Skills & Research Interests

Cell/gene therapy

Immunometabolism

Cancer metabolism

Tumor microenvironment

Extracellular

Top articles of Hongyun Zhao

Abstract LB027: In vivo delivery of novel CD89 fusion receptor to myeloid cells by mRNA activates anti-tumor immunity

Cancer Research

2023/4/14

Hongyun Zhao
Hongyun Zhao

H-Index: 5

Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth

Nature metabolism

2022/12

Hongyun Zhao
Hongyun Zhao

H-Index: 5

Da Teng
Da Teng

H-Index: 3

Lifeng Yang
Lifeng Yang

H-Index: 5

Jiajia Chen
Jiajia Chen

H-Index: 23

Yaqing Zhang
Yaqing Zhang

H-Index: 18

Lei Gu
Lei Gu

H-Index: 10

Li Cai
Li Cai

H-Index: 16

Marina Pasca Di Magliano
Marina Pasca Di Magliano

H-Index: 31

David Liu
David Liu

H-Index: 22

Bin Zheng
Bin Zheng

H-Index: 23

Abstract LB006: In vivo programming of myeloid cells by mRNA mediated delivery of novel Fc alpha fusion receptor activates anti-tumor immunity

Cancer Research

2022/6/15

Hongyun Zhao
Hongyun Zhao

H-Index: 5

1237 In vivo programming of myeloid cells by mRNA mediated delivery of novel Fca fusion receptor activates anti-tumor immunity

J Immunother

2022

Hongyun Zhao
Hongyun Zhao

H-Index: 5

Targeting immunometabolism of neoplasms by interleukins: A promising immunotherapeutic strategy for cancer treatment

Cancer Letters

2021/6

Hongyun Zhao
Hongyun Zhao

H-Index: 5

ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment

Nature communications

2020/7/15

Abhinav Achreja
Abhinav Achreja

H-Index: 13

Hongyun Zhao
Hongyun Zhao

H-Index: 5

Ying Zhu
Ying Zhu

H-Index: 9

Deepak Nagrath
Deepak Nagrath

H-Index: 25

See List of Professors in Hongyun Zhao University(Harvard University)